ReviewJournal of lipid and atherosclerosis2022

A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy.

Kyuho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.